Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
J Herrmann, D Lenihan, S Armenian… - European heart …, 2022 - academic.oup.com
Abstract The discipline of Cardio-Oncology has seen tremendous growth over the past
decade. It is devoted to the cardiovascular (CV) care of the cancer patient, especially to the …
decade. It is devoted to the cardiovascular (CV) care of the cancer patient, especially to the …
Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association
Cardiovascular disease (CVD) remains the leading cause of mortality in women, yet many
people perceive breast cancer to be the number one threat to women's health. CVD and …
people perceive breast cancer to be the number one threat to women's health. CVD and …
Cardio-oncology rehabilitation to manage cardiovascular outcomes in cancer patients and survivors: a scientific statement from the American Heart Association
SC Gilchrist, A Barac, PA Ades, CM Alfano… - Circulation, 2019 - Am Heart Assoc
Cardiovascular disease is a competing cause of death in patients with cancer with early-
stage disease. This elevated cardiovascular disease risk is thought to derive from both the …
stage disease. This elevated cardiovascular disease risk is thought to derive from both the …
Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and …
JC Plana, M Galderisi, A Barac, MS Ewer… - European Heart …, 2014 - academic.oup.com
Cardiac dysfunction resulting from exposure to cancer therapeutics was first recognized in
the 1960s, with the widespread introduction of anthracyclines into the oncological …
the 1960s, with the widespread introduction of anthracyclines into the oncological …
[PDF][PDF] Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline
SH Armenian, C Lacchetti, A Barac, J Carver… - J Clin …, 2017 - clf1.medpagetoday.com
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American
Society of Clinical Oncology Clinical P Page 1 City of Hope, Duarte, CA; American Society …
Society of Clinical Oncology Clinical P Page 1 City of Hope, Duarte, CA; American Society …
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools …
AR Lyon, S Dent, S Stanway, H Earl… - European journal of …, 2020 - Wiley Online Library
This position statement from the Heart Failure Association of the European Society of
Cardiology Cardio‐Oncology Study Group in collaboration with the International Cardio …
Cardiology Cardio‐Oncology Study Group in collaboration with the International Cardio …
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio‐Oncology Study Group of the Heart Failure …
R Pudil, C Mueller, J Čelutkienė… - European journal of …, 2020 - Wiley Online Library
Serum biomarkers are an important tool in the baseline risk assessment and diagnosis of
cardiovascular disease in cancer patients receiving cardiotoxic cancer treatments. Increases …
cardiovascular disease in cancer patients receiving cardiotoxic cancer treatments. Increases …
Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis
L Zhang, M Awadalla, SS Mahmood… - European heart …, 2020 - academic.oup.com
Aims Myocarditis is a potentially fatal complication of immune checkpoint inhibitors (ICI).
Sparse data exist on the use of cardiovascular magnetic resonance (CMR) in ICI-associated …
Sparse data exist on the use of cardiovascular magnetic resonance (CMR) in ICI-associated …
Cardiovascular health of patients with cancer and cancer survivors: a roadmap to the next level
A Barac, G Murtagh, JR Carver, MH Chen… - Journal of the American …, 2015 - jacc.org
Many existing and emerging cancer therapies have a significant effect on the cardiovascular
health of patients with cancer and cancer survivors. This paper examines current aspects of …
health of patients with cancer and cancer survivors. This paper examines current aspects of …
Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B
JR Basile, A Barac, T Zhu, KL Guan, JS Gutkind - Cancer research, 2004 - AACR
The semaphorins are a large family of secreted and cell surface proteins that provide
attractive and repulsive cues for axon guidance during neuronal development. Semaphorins …
attractive and repulsive cues for axon guidance during neuronal development. Semaphorins …